JANUS HENDERSON GROUP PLC - ALIGOS THERAPEUTICS INC ownership

ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 78 filers reported holding ALIGOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of ALIGOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$3,698,000
-87.1%
1,720,436
-28.9%
0.00%
-83.3%
Q4 2021$28,721,000
-23.7%
2,419,613
-0.9%
0.01%
-25.0%
Q3 2021$37,657,000
-17.8%
2,440,476
+8.0%
0.02%
-20.0%
Q2 2021$45,803,000
-6.0%
2,259,767
+1.3%
0.02%
-9.1%
Q1 2021$48,726,000
-2.6%
2,230,051
+17.7%
0.02%
-4.3%
Q4 2020$50,009,0001,893,9680.02%
Other shareholders
ALIGOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,320,381$27,543,00014.73%
Pivotal bioVenture Partners Investment Advisor LLC 876,548$10,405,0004.35%
Logos Global Management LP 3,112,785$36,949,0003.81%
Vivo Capital, LLC 3,547,030$42,103,0002.54%
Novo Holdings A/S 2,614,563$31,035,0001.47%
Boxer Capital, LLC 1,526,048$18,114,0000.70%
HHLR ADVISORS, LTD. 2,365,064$28,073,0000.43%
Cormorant Asset Management, LP 521,257$6,187,0000.37%
Baker Brothers Advisors 2,076,400$24,647,0000.12%
Sofinnova Investments, Inc. 127,791$1,517,0000.09%
View complete list of ALIGOS THERAPEUTICS INC shareholders